These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3056245)

  • 1. Carumonam versus ceftazidime for urinary tract infections.
    Edelstein H; Oster S; Cassano K; McCabe R
    Antimicrob Agents Chemother; 1988 Jul; 32(7):1031-3. PubMed ID: 3056245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carumonam versus ceftazidime: in vitro activity, pharmacokinetics in elderly patients, safety and therapeutic efficacy in the treatment of complicated urinary tract infections.
    Naber K; Kees F; Denk K; Bauernfeind A; Grobecker H
    Chemioterapia; 1987 Jun; 6(2 Suppl):517-8. PubMed ID: 3334613
    [No Abstract]   [Full Text] [Related]  

  • 3. Carumonam (Ro 17-2301; AMA-1080) compared with gentamicin for treatment of complicated urinary tract infections.
    Hoepelman AI; Bakker LJ; Verhoef J
    Antimicrob Agents Chemother; 1988 Apr; 32(4):473-6. PubMed ID: 3377459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo antibacterial activities of carumonam (AMA-1080), a new N-sulfonated monocyclic beta-lactam antibiotic.
    Imada A; Kondo M; Okonogi K; Yukishige K; Kuno M
    Antimicrob Agents Chemother; 1985 May; 27(5):821-7. PubMed ID: 3874598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study on aztreonam, ceftazidime and amikacin in the treatment of complicated urinary tract infections.
    Melekos MD; Skoutelis A; Chryssanthopoulos C; Bassaris HP
    J Chemother; 1991 Dec; 3(6):376-82. PubMed ID: 1819621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative antibacterial activity of a new monobactam, carumonam (RO 17-2301, AMA 1080) on hospital bacteria resistant to beta lactams].
    Le Noc P; Croize J; Le Noc D
    Pathol Biol (Paris); 1987 May; 35(5):451-6. PubMed ID: 3302846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carumonam in the treatment of severe and complicated urinary tract infections.
    Kotilainen P; Huovinen P; Hänninen P
    Chemioterapia; 1987 Jun; 6(2 Suppl):514-5. PubMed ID: 3509487
    [No Abstract]   [Full Text] [Related]  

  • 8. Carumonam and cefotiam in the treatment of complicated urinary tract infection (UTI): a randomized study.
    Westenfelder M; Frankenschmidt A; Pelz K
    Chemioterapia; 1987 Jun; 6(2 Suppl):515-6. PubMed ID: 3334612
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety and efficacy of cefepime versus ceftazidime in the treatment of severe infections.
    Huang CK; Chen YS; Lee SS; Lin WR; Tsai HC; Lin HH; Wann SR; Chen JY; Yen MY; Liu YC
    J Microbiol Immunol Infect; 2002 Sep; 35(3):159-67. PubMed ID: 12380788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical evaluation of the combination of carumonam and fosfomycin in the treatment of complicated urinary tract infection].
    Kakizaki H; Ishii N; Murakami S; Suzuki K; Takamizawa A; Hirano J; Mitobe K; Saito M; Hirano K; Imamura A
    Hinyokika Kiyo; 1990 Jun; 36(6):731-5. PubMed ID: 2239570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy of carumonam.
    Drabu YJ; Mehtar S; Blakemore PH
    Drugs Exp Clin Res; 1988; 14(10):665-7. PubMed ID: 3246211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anti-microbial activity, beta-lactamase stability, and disk diffusion susceptibility testing of carumonam (RO 17-2301, AMA-1080), a new monobactam.
    Jones RN; Barry AL; Thornsberry C; Fuchs PC; Packer RR
    Am J Clin Pathol; 1986 Nov; 86(5):608-18. PubMed ID: 3096130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aztreonam: worldwide overview of the treatment of patients with gram-negative infections.
    Henry SA; Bendush CB
    Am J Med; 1985 Feb; 78(2A):57-64. PubMed ID: 3881950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical evaluation of the combination of carumonam and cefotiam in the treatment of complicated urinary tract infection].
    Sonoda T; Nakano E; Seguchi T; Yano H; Kuroda H; Ihara Y; Kishimoto T; Takatera H; Mizutani S; Iwao N
    Hinyokika Kiyo; 1991 Feb; 37(2):203-9. PubMed ID: 2048503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefpirome versus ceftazidime in the treatment of urinary tract infections.
    J Antimicrob Chemother; 1992 Apr; 29 Suppl A():95-104. PubMed ID: 1601765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study of cefpirome and ceftazidime in complicated urinary tract infections].
    Naide Y; Aso Y; Oshi M; Kumamoto Y; Hirose T; Machida T; Tsuchida S; Suzuki K; Orikasa S; Kawada Y
    Hinyokika Kiyo; 1991 Apr; 37(4):447-64. PubMed ID: 1892004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, double-blind comparison of ceftazidime and moxalactam in complicated urinary tract infections.
    Horowitz EA; Preheim LC; Safranek TJ; Pugsley MP; Sanders CC; Bittner MJ
    Antimicrob Agents Chemother; 1985 Aug; 28(2):299-301. PubMed ID: 3914859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Empirical monotherapy with meropenem in serious bacterial infections. Meropenem Study Group.
    Mouton YJ; Beuscart C
    J Antimicrob Chemother; 1995 Jul; 36 Suppl A():145-56. PubMed ID: 8543490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceftazidime in the treatment of complicated respiratory and urinary tract infections.
    Loebis LH; Williams KJ
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():59-64. PubMed ID: 6352656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study.
    Carmeli Y; Armstrong J; Laud PJ; Newell P; Stone G; Wardman A; Gasink LB
    Lancet Infect Dis; 2016 Jun; 16(6):661-673. PubMed ID: 27107460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.